NCT06113380 Using Upper Limb Rehabilitation Robot in Stroke Patient Rehabilitation
| NCT ID | NCT06113380 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2023-10-25 |
| Primary Completion | 2025-12-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2023-10-25 with a primary completion date of 2025-12-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A robot arm for upper limb rehabilitation is intended to achieve rehabilitation effects through the study of robot control theory and the integration of sensors such as sEMG. The goal is to reduce the workload of rehabilitation therapists.
Eligibility Criteria
Inclusion Criteria: 1. First-time stroke, occurring between 2 weeks and 2 years after onset, resulting in unilateral hemiplegia. 2. Able to understand and follow simple instructions. 3. Able to maintain a sitting posture balance. 4. Rank on the Brunnstrom Scale is between two and five. 5. Both ischemic and hemorrhagic strokes are included. Exclusion Criteria: 1. Not yet fully conscious. 2. Suffering from a psychiatric disorder or post-stroke psychiatric abnormalities. 3. Cognitive or behavioral impairments that affect the ability to comprehend or execute the experimental tasks. 4. Severe aphasia preventing compliance with researchers' instructions for this study. 5. Medical conditions in internal medicine that jeopardize patient safety, such as severe heart or lung diseases, or patients requiring bed rest. 6. Patients with a severe systemic illness requiring bed rest. 7. Patients with shoulder joint pathology unable to undergo exercise therapy. 8. Patients with severe osteoporosis who have concerns about fractures during physical activity. 9. Patients with arrhythmia and implanted cardiac pacemakers. 10. Severe uncontrolled seizures that cannot be improved with medication, physical therapy, botulinum toxin injections, or phenol block procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06113380 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06113380 currently recruiting?
Yes, NCT06113380 is actively recruiting participants. Contact the research team at mntinglin@ntuh.gov.tw for enrollment information.
Where is the NCT06113380 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06113380 clinical trial?
NCT06113380 is sponsored by National Taiwan University Hospital. The trial plans to enroll 68 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.